Synthesis and biological evaluation of novel SIPI-7623 derivatives as farnesoid X receptor (FXR) antagonists

被引：0

作者：

Si-Yun Nian

Guo-Ping Wang

Zheng-Li Jiang

Ying Xiao

Mo-Han Huang

Yi-Huan Zhou

Xiang-Duan Tan

机构：

[1] Taizhou Hospital of Zhejiang Province,Department of Clinical Pharmacy

[2] China State Institute of Pharmaceutical Industry,Shanghai Institute of Pharmaceutical Industry

[3] Aurisco Pharmaceutical (Yangzhou) Co.,College of Pharmacy

[4] Ltd.,undefined

[5] Guilin Medical University,undefined

来源：

Molecular Diversity | 2019年 / 23卷

关键词：

FXR antagonists; Guggulsterone; Structure activity relationship; Molecular docking;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Most of reported steroidal FXR antagonists are restricted due to low potency. We described the design and synthesis of novel nonsteroidal scaffold SIPI-7623 derivatives as FXR antagonists. The most potent compound A-11 (IC50 = 7.8 ± 1.1 μM) showed better activity compared to SIPI-7623 (IC50 = 40.8 ± 1.7 μM) and guggulsterone (IC50 = 45.9 ± 1.1 μM). Docking of A-11 in FXR’s ligand-binding domain was also studied.

引用

页码：19 / 33

页数：14

共 50 条

[1] Synthesis and biological evaluation of novel SIPI-7623 derivatives as farnesoid X receptor (FXR) antagonists
Nian, Si-Yun
Wang, Guo-Ping
Jiang, Zheng-Li
Xiao, Ying
Huang, Mo-Han
Zhou, Yi-Huan
Tan, Xiang-Duan
MOLECULAR DIVERSITY, 2019, 23 (01) : 19 - 33
[2] Hypolipidemic effect of SIPI-7623, a derivative of an extract from oriental wormwood, through farnesoid X receptor antagonism
Deng Yi-Fang
Huang Xiao-Ling
Su Mei
Yu Peng-Xia
Zhang Zhen
Liu Quan-Hai
Wang Guo-Ping
Liu Min-Yu
CHINESE JOURNAL OF NATURAL MEDICINES, 2018, 16 (08) : 572 - 579
[3] Hypolipidemic effect of SIPI-7623,a derivative of an extract from oriental wormwood,through farnesoid X receptor antagonism
DENG Yi-Fang
HUANG Xiao-Ling
SU Mei
YU Peng-Xia
ZHANG Zhen
LIU Quan-Hai
WANG Guo-Ping
LIU Min-Yu
Chinese Journal of Natural Medicines, 2018, 16 (08) : 572 - 579
[4] Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists
Teno, Naoki
Iguchi, Yusuke
Yamashita, Yukiko
Mori, Nobuhiro
Une, Mizuho
Nishimaki-Mogami, Tomoko
Gohda, Keigo
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (06) : 1787 - 1794
[5] Synthesis and biological evaluations of chalcones, flavones and chromenes as farnesoid x receptor (FXR) antagonists
Zhang, Guoning
Liu, Shuainan
Tan, Wenjuan
Verma, Ruchi
Chen, Yuan
Sun, Deyang
Huan, Yi
Jiang, Qian
Wang, Xing
Wang, Na
Xu, Yang
Wong, Chiwai
Shen, Zhufang
Deng, Ruitang
Liu, Jinsong
Zhang, Yanqiao
Fang, Weishuo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 129 : 303 - 309
[6] Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists
Zhu, Yuanju
Zhang, Jay
Min, Feng
Yang, Xinying
Li, Li
Zhang, Yan
Hou, Xuben
Fang, Hao
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 76
[7] Synthesis and discovery of andrographolide derivatives as non-steroidal farnesoid X receptor (FXR) antagonists
Liu, Zhuyun
Law, Wai-Kit
Wang, Decai
Nie, Xin
Sheng, Dekuan
Song, Genrui
Guo, Kai
Wei, Ping
Ouyang, Pingkai
Wong, Chi-Wai
Zhou, Guo-Chun
RSC ADVANCES, 2014, 4 (26): : 13533 - 13545
[8] Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
Merk, Daniel
Gabler, Matthias
Gomez, Roberto Carrasco
Flesch, Daniel
Hanke, Thomas
Kaiser, Astrid
Lamers, Christina
Werz, Oliver
Schneider, Gisbert
Schubert-Zsilavecz, Manfred
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (08) : 2447 - 2460
[9] Design, Synthesis, and Biological Evaluation of Novel Nonsteroidal FarnesoidX Receptor (FXR) Antagonists: Molecular Basis of FXR Antagonism
Huang, Huang
Si, Pei
Wang, Lei
Xu, Yong
Xu, Xin
Zhu, Jin
Jiang, Hualiang
Li, Weihua
Chen, Lili
Li, Jian
CHEMMEDCHEM, 2015, 10 (07) : 1184 - 1199
[10] Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Lamers, Christina
Schubert-Zsilavecz, Manfred
Merk, Daniel
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (19) : 2188 - 2205

← 1 2 3 4 5 →